Page last updated: 2024-08-18

2-aminopyrimidine and crizotinib

2-aminopyrimidine has been researched along with crizotinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, S; Gong, P; Gou, W; Gu, Y; Hu, G; Wang, J; Wang, Y; Zhai, X; Zuo, D	1

Other Studies

1 other study(ies) available for 2-aminopyrimidine and crizotinib

Article	Year
Discovery of novel 2,4-diarylaminopyrimidine analogues as ALK and ROS1 dual inhibitors to overcome crizotinib-resistant mutants including G1202R. European journal of medicinal chemistry, 2018, Jan-01, Volume: 143 Topics: Anaplastic Lymphoma Kinase; Antineoplastic Agents; Apoptosis; Cell Proliferation; Crizotinib; Dose-Response Relationship, Drug; Drug Discovery; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Molecular Docking Simulation; Molecular Structure; Mutation; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pyrazoles; Pyridines; Pyrimidines; Receptor Protein-Tyrosine Kinases; Structure-Activity Relationship; Tumor Cells, Cultured	2018

Article

Year

Discovery of novel 2,4-diarylaminopyrimidine analogues as ALK and ROS1 dual inhibitors to overcome crizotinib-resistant mutants including G1202R.

European journal of medicinal chemistry, 2018, Jan-01, Volume: 143

Topics: Anaplastic Lymphoma Kinase; Antineoplastic Agents; Apoptosis; Cell Proliferation; Crizotinib; Dose-Response Relationship, Drug; Drug Discovery; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Molecular Docking Simulation; Molecular Structure; Mutation; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pyrazoles; Pyridines; Pyrimidines; Receptor Protein-Tyrosine Kinases; Structure-Activity Relationship; Tumor Cells, Cultured

2018